 BRENTWOOD, Tenn., Jan. 11, 2021 GLOBE NEWSWIRE -- Members of management of Surgery Partners, Inc. the Company will be meeting with investors as part of the 2021 J.P. Morgan Healthcare Conference the week of January 11th, 2021, including a presentation on Monday, January 11, 2021 at 2:50 p.m. Eastern Time. Based on results through November 2020, the Company is now providing full year 2020 revenue guidance of approximately 1.86 billion and reaffirming its previous full-year 2020 Adjusted EBITDA guidance range of 250 to 260 million. Consistent with previous management statements, the Company projects that in 2021, it will re-establish the multi-year double-digit Adjusted growth trajectory and profit levels originally targeted based on a pre-COVID baseline. Correspondingly, 2021 Adjusted EBITDA is projected to be approximately 315 million. This information is included in a Corporate Presentation that may be used for these meetings. The Corporate Presentation is available on the Companys website at ir.surgerypartners.comevents-and-presentationspresentations. 